Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H37ClO7 |
Molecular Weight | 521.042 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]3(Cl)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=KUVIULQEHSCUHY-XYWKZLDCSA-N
InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1
Molecular Formula | C28H37ClO7 |
Molecular Weight | 521.042 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:10:44 UTC 2023
by
admin
on
Fri Dec 15 15:10:44 UTC 2023
|
Record UNII |
5B307S63B2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
356311
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
111198
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
146501
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
144201
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
285609
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000091556
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
3002
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
1048506
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
5B307S63B2
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
294
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
BECLOMETHASONE DIPROPIONATE
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | Description: A white to creamy white powder; odourless. Solubility: Practically insoluble in water; soluble in 60 parts of ethanol (~750 g/l) TS. Category: Antiasthmatic drug. Storage: Beclometasone dipropionate should be kept in a well-closed container, protected from light. Definition: Beclometasone dipropionate contains not less than 96.0% and not more than 104.0% of C28H37ClO7, calculated with reference to the dried substance. | ||
|
DB00394
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
SUB00681MIG
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
1348
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | RxNorm | ||
|
5894
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
5B307S63B2
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
755901
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
CHEMBL1200500
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
226-886-0
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
DTXSID3048730
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
BECLOMETASONE DIPROPIONATE
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
C299
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
SUB26515
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
5534-09-8
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
21700
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | |||
|
m2287
Created by
admin on Fri Dec 15 15:10:45 UTC 2023 , Edited by admin on Fri Dec 15 15:10:45 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
DEGRADENT -> PARENT |
|
||
|
SOLVATE->ANHYDROUS | |||
|
TARGET -> AGONIST |
Binds to the glucocorticoid receptor with about half the affinity of the potent glucocorticoid dexamethasone (Dexa), B was found to be 0·75 times less active than Dexa.
|
||
|
DEGRADENT -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MINOR
PLASMA
|
||
|
METABOLITE LESS ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PRODRUG |
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
http://apps.who.int/phint/pdf/b/Jb.6.1.43.pdf
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
17-BMP is about 13 times as potent as Dexa.
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||